Korea's food and drug ministry courts digital medicine firms with policy briefing
The food and drug safety ministry convened device and drug developers in Seoul to gather input for next year's digital medical product policy.

The food and drug safety ministry said Tuesday it held a meeting with digital medical device and digital combination drug companies in Seoul to shape its policy direction for next year, pitching the sector as a chance for Korea to build on its technology strength.
"Digital combination drugs are a new opportunity for Korea, a digital powerhouse, to leverage its strengths and take a leap forward in the bio and pharmaceutical industries," Minister Oh Yu-kyoung said, according to the ministry. She added that the government would be a reliable partner so that companies can innovate and take on challenges.
The gathering at the EL Tower in Yangjae, Seocho District, brought the two industries together in separate sessions, the ministry said. Discussions covered this year's digital medical device policy achievements and industry views on the 2027 policy direction, along with an explanation of the digital combination drug policy and a question-and-answer session.
Digital combination drugs pair a medicine with an artificial intelligence or software-based medical device rather than relying on the drug alone, with the aim of improving treatment effects or adjusting dosage. Korea enacted a dedicated Digital Medical Products Act in January 2024, the first such legislation in the world, and began operating the digital combination drug system in January 2025.
The meeting follows the ministry's presentation of a digital combination drug policy as a regulatory rationalization task at an Oct. 23 meeting of the Presidential Regulatory Rationalization Committee. Oh visited a company developing such products on Monday.
The ministry said it will review the opinions raised at the meeting and reflect them in next year's digital medical product policy. It also plans an explanatory session for industry at the Ruby Hall of the EL Tower on Tuesday, guidelines on areas such as clinical trials for digital combination drugs in December, and an overhaul of related regulations in January 2027.
What this article is based on
Every fact in this article can be checked against the primary documents below.
- Government식품의약품안전처 정부 보도자료· Ministry of Food and Drug Safety· accessed Nov. 17, 2026
- Government간담회 개최 개요· korea.kr· accessed Nov. 17, 2026
- Government오유경 처장 발언 (디지털융합의약품 기회)· korea.kr· accessed Nov. 17, 2026
© New Era Korea Daily. All rights reserved.